Assessing constituent levels in smokeless tobacco products: A new approach to engaging and educating the public

Nicotine and Tobacco Research

Volumn 17, Issue 11, 2015, Pages 1354-1361

  Borgida, Eugene ^a   Loken, Barbara ^b   Williams, Allison L ^a   Vitriol, Joseph ^a   Stepanov, Irina ^a   Hatsukami, Dorothy ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; CARCINOGEN;

ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CONSUMER HEALTH INFORMATION; EXPERIMENTAL STUDY; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH HAZARD; HUMAN; NICOTINE REPLACEMENT THERAPY; PRIORITY JOURNAL; SMOKELESS TOBACCO; TOBACCO USE; ADULT; ANALYSIS; CONTROLLED STUDY; FEMALE; HIGH RISK BEHAVIOR; MALE; PACKAGING; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; UNITED STATES;

ADULT; CARCINOGENS; FEMALE; HEALTH EDUCATION; HUMANS; MALE; PRODUCT LABELING; RISK-TAKING; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; TOBACCO, SMOKELESS; UNITED STATES;

EID: 84946748890     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv007     Document Type: Article

References (34)

1. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
2. Biener L, Bogen K, Connolly G. Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products. Tob Control. 2007;16:306-311.
3. Callery WE, Hammond D, O'Connor RJ, et al. The appeal of smokeless tobacco products among young Canadian smokers: the impact of pictorial health warnings and relative risk messages. Nicotine Tob Res. 2011;13:373-383.
4. Øverland S, Hetland J, Aarø LE. Relative harm of snus and cigarettes: what do Norwegian adolescents say? Tob Control. 2008;17:422-425.
5. O'Connor RJ, McNeill A, Borland R, et al. Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration. Nicotine Tob Res. 2007;9:1033-1042.
6. Smith SY, Curbow B, Stillman FA. Harm perception of nicotine products in college freshmen. Nicotine Tob Res. 2007;9:977-982.
7. Bansal MA, Cummings KM, Hyland A, et al. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res. 2004;6:S303-S310.
8. Cummings KM, Hyland A, Giovino GA, et al. Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res. 2004;6:S333-S340.
9. Shiffman S, Ferguson SG, Rohay J, et al. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008;103:1371-1378.
10. Hecht S, Stepanov I, Hatsukami D. Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products. Tob Control. 2011;20:443.
11. Stepanov I, Jensen J, Hatsukami D, et al. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008;10:1773-1782.
12. Biener L, Nyman AL, Stepanov I, et al. Public education about the relative harm of tobacco products: an intervention for tobacco control professionals. Tob Control. 2014;23:385-388.
13. Borland R, Li L, Cummings KM, et al. Effects of a Fact Sheet on beliefs about the harmfulness of alternative nicotine delivery systems compared with cigarettes. Harm Reduct J. 2012;9:19.
14. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
15. U.S. Department of Health and Human Services. The Health Consequences of Smoking: Nicotine and Addiction. A Report of the Surgeon General. Report No.: DHHS Publication No. (CDC) 88-8406. Rockville, MD; U.S. Department of Health and Human Services; 1988.
16. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998;11:559-603.
17. International Agency for Research on Cancer. Smokeless Tobacco and Tobacco-Specific Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 89. Lyon, France: IARC; 2007.
18. Food and Drug Administration, Center for Tobacco Products CTP. Guidance for Industry. Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under Section 904(a)(3) of the Federal Food, Drug, and Cosmetic Act. Draft Guidance. Silver Spring, MD: U.S. Department of Health and Human Services, FDA, Center for Tobacco Products; 2012.
19. Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res. 2003;5:561-569.
20. Foulds J, Ramstrom L, Burke M, Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003;12:349-359.
21. Ramstrom L, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control. 2006;15:210-214.
22. Frey D. Recent research on selective exposure to information. Adv Exp Soc Psychol. 1986;19:41-80.
23. Smith SM, Fabrigar LR, Norris ME. Reflecting on six decades of selective exposure research: progress, challenges, and opportunities. Soc Personal Psychol Compass. 2008;2:464-493.
24. Stepanov I, Biener L, Yershova K, et al. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch. Nicotine Tob Res. 2014;16:1070-1078.
25. Richter P, Hodge K, Stanfill S, Zhang L, Watson C. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine Tob Res. 2008;10:1645-1652.
26. Tomar SL, Henningfield JE. Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. Tob Control. 1997;6:219-225.
27. Hatsukami DK, Severson HH. Oral spit tobacco: addiction, prevention and treatment. Nicotine Tob Res. 1999;1:21-44.
28. Fant RV, Henningfield JE, Nelson RA, Pickworth WB. Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tob Control. 1999;8:387-392.
29. Aiken LS, West SG. Multiple Regression: Testing and Interpreting Interactions. London, UK: Sage; 1991.
30. Hammond D. Health warning messages on tobacco products: a review. Tob Control. 2011;20:327-337.
31. O'Connor RJ. Non-cigarette tobacco products: what have we learnt and where are we headed? Tob Control. 2012;21:181-190.
32. Stepanov I, Jensen J, Hatsukami D, et al. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res. 2006;8:309-313.
33. Djordjevic M, Brunnemann K, Hoffmann D. The need for regulation of carcinogenic N-nitrosamines in oral snuff. Food Chem Toxicol. 1993;31:497-501.
34. Chamberlain WJ, Schlotzhauer WS, Chortyk OT. Chemical composition of nonsmoking tobacco products. J Agric Food Chem. 1988;36:48-50.